Literature DB >> 870640

Segmental analysis of Ti-201 stress myocardial scintigraphy.

A Lenaers, P Block, E V Thiel, M Lebedellr, P Becquevort, F Erbsmann, A Ermans.   

Abstract

Thallium-201 scintigraphy of the exercised myocardium was performed in 70 male patients admitted for coronary arteriography and left-ventricular angiography. Left ventricular scintigrams were collected in left lateral, left anterior oblique (65 degrees, 45 degrees, and 25 degrees), and anterior views, and the images were divided into eight segments: apical, anteroseptal, anterior, antero-lateral, posterolateral, posterior, inferior, and posteroseptal. A correlative study between segmental hypoperfusion on scintigram and coronary-artery stenosis visualized by contrast artriorgraphy allowed selection of specific segments for each main coronary artery. Hypoactivity in the apical and posterior segments did not appear reliable. Using selected segments, we were able to identify LAD disease in 84%, LCx disease in 49%, and RCA disease in 79% of documented significant stenosis, with specificity of 95%, 89%, and 88%, respectively. Coronary-artery disease could be detected in 95% of patients having more than 50% coronary-artery stenosis, with 93% specificity. In most cases, patients with two-vessels disease and three-vessel disease could not be distinguished from each other. Multiple-vessel disease suggested by segmental analysis of myocardial scinitgrams after exercise was confirmed artriographically in 88% of the patients, but 52% with scintigrams suggesting signle-vessel disease had, in fact, multiple-vessel disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870640

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

1.  A comparison of maximal exercise and dipyridamole thallium-201 planar gated scintigraphy.

Authors:  W Martin; A C Tweddel; G Main; I Hutton
Journal:  Eur J Nucl Med       Date:  1992

2.  Thallium myocardial perfusion scintigraphy: influence of perfusion, scatter, and photon energy on the detection of lesions.

Authors:  P H Vos; E K Pauwels; A M Vossepoel
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

3.  Improved detection of coronary artery disease by estimated myocardial thallium uptake.

Authors:  A C Tweddel; W Martin; I McGhie; I Hutton
Journal:  Eur J Nucl Med       Date:  1989

4.  Specific perfusion pattern in stress 201Tl myocardial scintigraphy of left main coronary artery disease.

Authors:  S Wakasugi; N Shibata; T Kobayashi; Y Fudemoto; Y Hasegawa; S Nakano
Journal:  Eur J Nucl Med       Date:  1986

5.  Automatic drawing of the left epicardial region of interest on thallium 201 scintigraphic images.

Authors:  H Valette; M Bourguignon; K Douglass; A del Buono; P Merlet; J W Buchanan; C Raynaud; A Syrota; H N Wagner
Journal:  Eur J Nucl Med       Date:  1988

6.  Evaluation of thallium-201 exercise scintigraphy in coronary heart disease.

Authors:  R G Murray; J H McKillop; R G Bessent; J G Turner; A R Lorimer; I Hutton; W R Greig; T D Lawrie
Journal:  Br Heart J       Date:  1979-05

7.  Myocardial imaging with dipyridamole: comparison of the sensitivity and specificity of 201Tl versus MUGA.

Authors:  D Harris; D Taylor; B Condon; D Ackery; N Conway
Journal:  Eur J Nucl Med       Date:  1982

8.  Thallium-201 myocardial imaging in assessment of results of aortocoronary bypass surgery.

Authors:  P S Robinson; B T Williams; M M Webb-Peploe; A Crowther; D J Coltart
Journal:  Br Heart J       Date:  1979-10

9.  The significance of the abnormal rest thallium-201 myocardial image in coronary artery disease.

Authors:  J H McKillop; R G Murray; R G Bessent; J G Turner; W R Greig; A R Lorimer
Journal:  Eur J Nucl Med       Date:  1979-04-01

10.  Myocardial emission tomography with thallium-201. Value of multiple and orthogonal sections in the study of the myocardial infarction.

Authors:  J Maublant; J Cassagnes; M Jourde; A Veyre; G Meyniel
Journal:  Eur J Nucl Med       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.